Services.
Micelle 60 services open in stages. They include medical information and a safety route. They include lot results, care-organization support, and a statement of principle about how we intend to work.
Service directory
Every service, explained.
Choose a service. See what it does. See how it works. See what it includes. See what you can do today.
Medical information desk
Written, referenced answers about Micelle 60 for clinicians, pharmacists, and care organizations. Product questions are routed by email today; a dedicated desk will be named before first release.
Learn moreSafety reporting and notices
Report a product concern by email, phone, correspondence, or FDA MedWatch. A dedicated Micelle safety route will be named before first release.
Learn moreLot pages
Each released lot is planned to have one page with its selected certificate, CBD and total THC results, full test panel, stability results, re-tests, corrections, and notices.
Learn moreMicelle 60 Access Program
The program is designed to help care organizations put plans in place. It includes plan forms, eligibility and shared-decision forms, lot records, physician learning, patient materials, quarterly reports, and organizational implementation support.
Learn moreHow we intend to work
Micelle 60 is one product with one strength. That makes it possible to document it completely, and we intend to.
Learn moreChange log
The website log is available now. A lot-level change log is planned to open with the first released lot and record relevant controlled changes before an affected lot ships.
Learn moreProfessional information
Review the product, Quality Passport examples, organization framework, and dated readiness actions in one canonical professional area.
Learn morePatient information
Review patient information, visit preparation, bottle checks, and concern routes without entering a separate demo host.
Learn moreUS evidence module
Participating care organizations will be able to record use, tolerability, product concerns, and consented discontinuations for their own reporting.
Learn moreCaregiver material
The planned material includes a caregiver guide, lot notices, and large-print formats.
Learn moreQuality Passport
Open the single public Quality Passport route to look up a lot and review sample certificates, notices, and corrections.
Open the exampleReminders and notices
Lot-linked notices and any subscription controls will be described and tested before activation.
Learn moreTransition brief
The narrower Section 781 exclusions begin November 12, 2026. The broader finished-product restriction, including the more-than-0.4 mg combined-total-per-container threshold, begins December 11, 2026. This federal threshold does not by itself establish that Micelle 60 is compliant, approved, released, or eligible for any CMS program. State law and product-specific testing still matter.
Learn moreOncology practices
Oncology practices can review the EOM program context and organization responsibilities. Product supply remains gated.
Learn moreSpanish and accessible formats
Spanish page structure and large-text mode are available. Professional Spanish review and working audio files remain pending.
Learn more